Use App
New
Connect your Agent
Trending
News
Earnings
All
DIA
0.89%
SPY
0.17%
QQQ
0.19%
Trending
ZETA
11.83%
GLD
4.35%
AMD
7.24%
APPS
38.49%
UBER
6.25%
SHOP
18.34%
LLY
2.31%
SPCX
7.97%
ANET
5.36%
ALAB
10.03%
Feed
News
Sentiment
Earnings
Fundamentals
Info
home
Symbol
MDNAF
news
Exchange:
OTC
·
Updated 10:17 AM EDT
News
all
press releases
Medicenna Therapeutics (MDNAF) Upgraded to Buy: Here's What You Should Know
Medicenna Therapeutics (MDNAF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
<
1
>
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile